Reproxalap Improves Ocular Redness, Tear Production, and Symptoms in a Pivotal Dry Eye Disease Chamber Trial

Sumit Garg, Eric Donnenfeld, John Sheppard, Alice Epitropoulos, Todd C. Brady

Open source

DOI
10.1016/j.xops.2025.100938
Published
2026-01
Container
Ophthalmology Science
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.xops.2025.100938,
  title = {Reproxalap Improves Ocular Redness, Tear Production, and Symptoms in a Pivotal Dry Eye Disease Chamber Trial},
  author = {Sumit Garg and Eric Donnenfeld and John Sheppard and Alice Epitropoulos and Todd C. Brady},
  year = {2026},
  journal = {Ophthalmology Science},
  doi = {10.1016/j.xops.2025.100938},
  url = {https://doi.org/10.1016/j.xops.2025.100938}
}

RIS

TY  - JOUR
TI  - Reproxalap Improves Ocular Redness, Tear Production, and Symptoms in a Pivotal Dry Eye Disease Chamber Trial
AU  - Sumit Garg
AU  - Eric Donnenfeld
AU  - John Sheppard
AU  - Alice Epitropoulos
AU  - Todd C. Brady
PY  - 2026
JO  - Ophthalmology Science
DO  - 10.1016/j.xops.2025.100938
UR  - https://doi.org/10.1016/j.xops.2025.100938
ER  - 

APA

Garg, S., Donnenfeld, E., Sheppard, J., Epitropoulos, A., & Brady, T. C. (2026). Reproxalap Improves Ocular Redness, Tear Production, and Symptoms in a Pivotal Dry Eye Disease Chamber Trial. Ophthalmology Science. https://doi.org/10.1016/j.xops.2025.100938

Source records